4//SEC Filing
Michelon Francois Roger 4
Accession 0001209191-18-058719
CIK 0001681682other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 4:17 PM ET
Size
7.5 KB
Accession
0001209191-18-058719
Insider Transaction Report
Form 4
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
- Conversion
Common Stock
2018-11-13$1.68/sh+5,953$10,001→ 32,497 total - Conversion
Convertible Promissory Note
2018-11-13$10000.00/shExercise: $1.68Exp: 2018-12-31→ Common Stock (5,953 underlying)
Footnotes (2)
- [F1]These shares of Common Stock were issued upon the conversion of the Convertible Promissory Note described in footnote (2).
- [F2]Pursuant to the terms of the Convertible Promissory Note (the "Note"), the principal amount of the Note automatically converted into shares of the Issuer's Common Stock upon the consummation of a Qualified Financing (as defined in the Note) at the lowest per share price at which Common Stock was sold by the Issuer in the Qualified Financing, less a discount of 20%.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001691470
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 4:17 PM ET
- Size
- 7.5 KB